A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 1, 2006, Pages 42-51

  Golin, Carol E ^a,b,c   Earp, JoAnne ^b   Tien, Hsiao Chuan ^b   Stewart, Paul ^b   Porter, Carol ^c   Howie, Lynn ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antiretroviral adherence; Medication compliance; Motivational interviewing

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DRUG TREATMENT FAILURE; ETHNOLOGY; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT; VIRUS LOAD;

ACADEMIC MEDICAL CENTERS; ADULT; ANTI-RETROVIRAL AGENTS; DIRECTIVE COUNSELING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERVENTION STUDIES; INTERVIEWS; MALE; MOTIVATION; PATIENT COMPLIANCE; PROGRAM EVALUATION; TREATMENT FAILURE; TREATMENT REFUSAL; VIRAL LOAD;

EID: 33745466408     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000219771.97303.0a     Document Type: Article

References (62)

1. Liu HH, Golin CG, Miller L, et al. A comparison of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
2. Fogarty L, Roter D, Larson S, et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93-108.
3. Altice F, Friedland G. The era of adherence to HIV therapy. Ann Intern Med. 1998;129(6):503-505.
4. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV resistance. JAMA. 1998;279(24):1977-1983.
5. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357-366.
6. Weidle PJ, Ganera CE, Irwin KL, et al. Adherence to antiretroviral medications in an inner-city population. J AIDS. 1999;22:498-502.
7. Holzemer W, Henry S, Portillo CJ, et al. The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. J Assoc Nurses AIDS Care. 2000;11(1):36-44.
8. Murphy D, Roberts K, Martin DJ, et al. Barriers to antiretroviral adherence among HIV-Infected adults. AIDS Patient Care. 2000;14(1):47-58.
9. Chesney M, Ickovics J, Chambers D, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence Instruments. AIDS Care. 2000;12(3):255-266.
10. Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J AIDS. 2000;24:123-128.
11. Catz S, Kelly J, Bogart L, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124-133.
12. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs. 1999;13(3):185-197.
13. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14:267-273.
14. Tuldra A, Fumaz C, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to HAART. JAIDS. 2000;25:221-228.
15. Gifford A, Bormann J, Shively M, et al. Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug antiretroviral regimens. JAIDS. 2000;23:386-395.
16. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS. 2000;14:155-168.
17. Gordillo V, del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-1769.
18. Proctor VE, Tesfa A, Tompkins DC. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS. AIDS Patient Care STDS. 1999;13:535-544.
19. Meystre-Agustoni G, Dubois-Arber F, Cochand P, et al. Antiretroviral therapies from the patient's perspective. AIDS Care. 12(6):17-721.
20. Turner B, Newschaffer C, Zhang D, et al. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV infected women. Med Care. 2000;38(9):911-925.
21. Golin CE, Lui H, Hays R, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(9):1-10.
22. Simoni JM, Frick PA, Pantalone DW, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185-198.
23. Haddad M, Inch C, Glazier RH, et al. Patient Support and Education for Promoting Adherence to Highly Active Antiretroviral Therapy for HIV/AIDS (Cochrane Review). Cochrane Database System Review; 2002; CD001442.
24. Haynes RB, Taylor DW, Sackett DL. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979.
25. Roter DL, Hall HA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care. 1998;36:1138-1161.
26. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care. 1996;19:1153-1164.
27. Greenfield S, Kaplan SH, Ware JE Jr, et al. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988:448-457.
28. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd ed. New York: Guilford Press, 2002.
29. Emmons KM, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med. 2001;20(1):68-74.
30. Harding R, Dockrell MJ, Dockrell J, et al. Motivational interviewing for HIV risk reduction among gay men in commercial and public sex settings. AIDS Care. 2001;13:493-501.
31. Resnicow K, Jackson A, Wang T, et al. A motivational interviewing intervention to increase fruit and vegetable intake through Black churches: results of the Eat for Life trial. Am J Public Health. 2001;91(10):1686-1693.
32. Thevos AK, Quick RE, Yanduli V. Motivational interviewing enhances the adoption of water disinfection practices in Zambia. Health Promot Int. 2000;15(3):207-214.
33. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413-419.
34. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71(5):843-861.
35. Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from MI across behavioral domains: a systematic review. Addiction. 2001;96:1725-1742.
36. Adamian MS, Golin CE, Shain LS, et al. Brief motivational interviewing to improve adherence to antiretroviral therapy: development and qualitative pilot assessment of an intervention. AIDS Patient Care STDS. 2004;18(4):229-238.
37. Dilorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14(2):52-62.
38. Thrasher, A, Golin CE, Earp JA, et al. Motivational Interviewing to Improve Antiretroviral Adherence: The Role of Quality Assessment. Patient Educ Couns. 2005(July 13).
39. Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Educ Couns. 2004;53(2):147-155.
40. Deleted in proof.
41. Bandura A. self-efficiency: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191-215.
42. Anderson L. Health care communication and selected psychological adherence in diabetes management. Diabetes Care. 1990;13:66-67.
43. Macharia WM, Leon G, Rowe B, et al. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992;267:1813-1817.
44. Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence. 6th Conference on Retroviruses and Opportunistic Infections, 1999.
45. Fleishman JA, Sherbourne CD, Crystal S, et al. Coping, conflictual social interactions, social support and mood among HIV-infected persons. Am J Com Psych. 2000;28:421-453.
46. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. J AIDS. 2000;25:115-123.
47. Hays RD, Shaul JA, Williams VSL, et al. Psychometric properties of the CAHPSTM 1.0 Survey measures. Consumer Assessment of Health Plans Study. Med Care. 1999;37:MS22-MS31.
48. Kao AC, Green DC, Davis NA, et al. Patients' trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med. 1998;13:681-686.
49. Kaplan SH, Greenfield S, Gandek B, et al. Characteristics of physicians with participatory decision-making styles. Ann Intern Med. 1996;124(5):497-504.
50. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.
51. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-714.
52. Levy RW, Rayner CR, Fairley CK, et al. Melbourne Adherence Group. Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDS. December 2004;18(12):728-735.
53. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr. October 1, 2003;34(2):191-194.
54. Weber R, Christen L, Christen S, et al. Swiss HIV Cohort Study. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther. February 2004;9(1):85-95.
55. McCullagh P, Nelder JA. Generalized Linear Models, 2nd ed. London: Chapman & Hall; 1989.
56. Green LW. How physicians can improve patients' participation and maintenance in self-care. West J Med. 1987;147:346-349.
57. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-1510.
58. Safren SA, Hendriksen ES, Desousa N, et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. December 2003;15:787-793.
59. Green LW. How physicians can improve patients' participation and maintenance in self-care. West J Med. 1987;147:346-349.
60. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-1510.
61. Fisher EB, Brownson CA, O'toole ML, et al. Ecological approaches to self-management: the case of diabetes. Am J Public Health. 2005;5:1523-1535.
62. Currie GP, Devereux GS, Lee DK, et al. Recent developments in asthma management. BMJ. 2005 Mar 12;330(7491):585-589.